World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
9375
World Ranking
3992
National Ranking
1823

Janardan P. Pandey publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Janardan P. Pandey sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 244 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Janardan P. Pandey D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Janardan P. Pandey sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Janardan P. Pandey is affiliated with the Medical University of South Carolina in the United States. Their research spans primarily across the fields of Medicine and Immunology and Microbiology, with notable expertise in subfields such as Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Genetics, and Physiology.

The scientist's work covers several specific research topics, including monoclonal and polyclonal antibodies research, SARS-CoV-2 and COVID-19 research, Alzheimer's disease research and treatments, HIV research and treatment, diabetes and associated disorders, glycosylation and glycoproteins research, as well as T-cell and B-cell immunology.

Frequent publication venues for Janardan P. Pandey include:

  • The Journal of Immunology
  • Immunogenetics
  • JCI Insight
  • Journal of Alzheimer s Disease
  • Proceedings of the National Academy of Sciences

Their collaborative work involves several co-authors who have contributed to multiple publications together. Frequent co-authors are:

  • Aryan M. Namboodiri
  • Paul J. Nietert
  • Sandeep Narpala
  • Michelle Conan-Cibotti
  • Bob C. Lin

Recent notable papers authored or co-authored by Janardan P. Pandey include:

  • Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial (2022, Nature Medicine)
  • An Ig γ Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E ε4 Genotype (2020, The Journal of Immunology)
  • PILRA polymorphism modifies the effect of APOE4 and GM17 on Alzheimer's disease risk (2022, Scientific Reports)
  • Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer's disease (2020, Journal of Translational Medicine)
  • Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS (2024, JCI Insight)

Best Publications

  • Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    Rebecca M. Lynch;Eli Boritz;Emily E. Coates;Adam DeZure

  • HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites

    Milton D. Rossman;Bruce Thompson;Margaret Frederick;Mary Maliarik

  • Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis.

    E. A. Gore;J. J. Sanders;J. P. Pandey;Y. Palesch

  • Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.

    J. E. Ledgerwood;E. E. Coates;G. Yamshchikov;J. G. Saunders

  • Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.

    Martin R. Gaudinski;Emily E. Coates;Katherine V. Houser;Grace L. Chen

  • Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis

    G. M. P. Galbraith;T. M. Hendley;J. J. Sanders;Y. Palesch

  • CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region.

    Lori L. Hudson;Keith Rocca;Yeong W. Song;Janardan P. Pandey

  • The role of genetic factors in autoimmune disease: implications for environmental research.

    Glinda S. Cooper;Frederick W. Miller;Janardan P. Pandey

  • Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.

    April Bingham;April Bingham;Gulnara Mamyrova;Kristina I. Rother;Elif Oral;Elif Oral

  • Is occupational organic solvent exposure a risk factor for scleroderma

    Paul J. Nietert;Susan E. Sutherland;Richard M. Silver;Janardan P. Pandey

  • Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases.

    Filemon K. Tan;Frank C. Arnett;Stephan Antohi;Shinichiro Saito

  • ASSOCIATION BETWEEN IMMUNOGLOBULIN ALLOTYPES AND IMMUNE RESPONSES TO HÆMOPHILUS INFLUENZÆ AND MENINGOCOCCUS POLYSACCHARIDES

    J.P. Pandey;G. Virella;C.B. Loadholt;H.H. Fudenberg

  • Current Comment: Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis

    Janardan P. Pandey;E. Carwile LeRoy

  • Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: Ethnogeographic influences in the genetics and clinical expression of myositis

    Ejaz A. Shamim;Ejaz A. Shamim;Lisa G. Rider;Janardan P. Pandey;Terrance P. O'Hanlon

  • Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.

    D M Granoff;P G Shackelford;B K Suarez;M H Nahm

  • Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata.

    Gillian M. P. Galbraith;Janardan P. Pandey

  • Tumor Necrosis Factor Alpha Production by Oral Leukocytes: Influence of Tumor Necrosis Factor Genotype

    Gillian M. P. Galbraith;R. Britt Steed;John J. Sanders;Janardan P. Pandey

  • Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.

    Christine G. Parks;Glinda S. Cooper;Lori L. Hudson;Mary Anne Dooley

  • Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.

    M. S. Pollack;B. Safai;P. L. Myskowski;J. W. M. Gold

  • Enzyme‐linked immunosorbent assay for detection of Anti–RNA polymerase III antibody: Analytical accuracy and clinical associations in systemic sclerosis

    Masataka Kuwana;Yutaka Okano;Janardan P. Pandey;Richard M. Silver

Frequent Co-Authors

Dan M. Granoff
Dan M. Granoff UCSF Benioff Children's Hospital
Frederick W. Miller
Frederick W. Miller National Institutes of Health
Richard M. Silver
Richard M. Silver Medical University of South Carolina
Lisa G. Rider
Lisa G. Rider National Institutes of Health
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Shoichiro Tsugane
Shoichiro Tsugane International University of Health and Welfare
Motoki Iwasaki
Motoki Iwasaki National Cancer Research Institute, UK
Calogero Caruso
Calogero Caruso University of Palermo
Gary S. Gilkeson
Gary S. Gilkeson Medical University of South Carolina
Robert C. Elston
Robert C. Elston Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open new career opportunities in healthcare and research. Nursing pathways, especially, offer specialized roles that complement immunological knowledge.

Prospective students looking for flexible options may find programs that rank as the which nurse practitioner program is easiest appealing, allowing a smoother transition into advanced practice roles.

Mental health is an important frontier linked to immunology, with Psychiatric Mental Health Nurse Practitioner (PMHNP) roles gaining prominence. Identifying the best pmhnp programs online ensures quality training combined with strong clinical experiences.

Cost is a major consideration. For students seeking economical options, understanding cheapest psych np programs can make advanced education more accessible.

Career prospects are promising. According to data on doctorate in nursing salary, graduates with these degrees can expect competitive compensation that varies by location and specialization.

By aligning immunology studies with these online nursing pathways, students can enhance their expertise and expand their impact on public health and clinical practice.

Best Scientists Citing Janardan P. Pandey

Trending Scientists

Recently Published Articles